Search Results

Filter
  • 10-20 of  115,848 results for ""Antibodies, Viral""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cryptic-site-specific antibodies to the SARS-CoV-2 receptor binding domain can retain functional binding affinity to spike variants.

  • Authors : Li K; Center for Human Systems Immunology, Duke University, Durham, North Carolina, USA.; Department of Surgery, Duke University, Durham, North Carolina, USA.

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/chemistry ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/metabolism SARS-CoV-2 variants

  • Source: Journal of virology [J Virol] 2023 Dec 21; Vol. 97 (12), pp. e0107023. Date of Electronic Publication: 2023 Nov 29.Publisher: American Society For Microbiology Country of Publication: United States NLM ID: 0113724 Publication Model: Print-Electronic Cited Medium:

Record details

×
Editorial & Opinion

Antibody Titers against Mpox Virus after Vaccination.

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/analysis ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; Monkeypox virus*/Monkeypox virus*/Monkeypox virus*/immunology

  • Source: The New England journal of medicine [N Engl J Med] 2023 Dec 14; Vol. 389 (24), pp. 2299-2301.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Distinguishing features of long COVID identified through immune profiling.

  • Authors : Klein J; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.; Wood J

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; Herpesvirus 4, Human*/Herpesvirus 4, Human*/Herpesvirus 4, Human*/immunology

  • Source: Nature [Nature] 2023 Nov; Vol. 623 (7985), pp. 139-148. Date of Electronic Publication: 2023 Sep 25.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection.

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/analysis ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/analysis SARS-CoV-2 variants

  • Source: The New England journal of medicine [N Engl J Med] 2023 Oct 26; Vol. 389 (17), pp. 1626-1628.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream.

Subjects: Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; COVID-19*/COVID-19*/COVID-19*/blood

  • Source: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2023 Oct 01; Vol. 34 (7), pp. 439-445. Date of Electronic Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9102551 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Human cytomegalovirus glycoprotein B genotypic distributions and viral load in symptomatic infants.

  • Authors : Mu H; Department of Clinical Laboratory, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.; Qiao W

Subjects: Antibodies, Viral* ; Cytomegalovirus*/Cytomegalovirus*/Cytomegalovirus*/genetics ; Viral Envelope Proteins*

  • Source: Journal of infection in developing countries [J Infect Dev Ctries] 2023 Dec 31; Vol. 17 (12), pp. 1806-1813. Date of Electronic Publication: 2023 Dec 31.Publisher: Open Learning on Enteric Pathogens Country of Publication: Italy NLM ID: 101305410 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

[Controversies, difficulties and changes in serological confirmatory testing].

  • Authors : Zóka A; 1 Dél-pesti Centrumkórház, Országos Hematológiai és Infektológiai Intézet, Központi Laboratórium, Mikrobiológiai Profil 1097 Budapest, Albert Flórián út 5-7. Magyarország.; Gönczi M

Subjects: Antibodies, Viral* ; Coronavirus Infections*; Humans

  • Source: Orvosi hetilap [Orv Hetil] 2023 Dec 31; Vol. 164 (52), pp. 2065-2073. Date of Electronic Publication: 2023 Dec 31 (Print Publication: 2023).Publisher: Akademiai Kiado Country of Publication: Hungary NLM ID: 0376412 Publication Model: Electronic-Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Development of hybrid immunity during a period of high incidence of Omicron infections.

Subjects: Antibodies, Viral* ; Adaptive Immunity*; Humans

  • Source: International journal of epidemiology [Int J Epidemiol] 2023 Dec 25; Vol. 52 (6), pp. 1696-1707.Publisher: Oxford University Press Country of Publication: England NLM ID: 7802871 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

An ACE2-Based Bimodular Fusion Protein Enables Reorientation of Endogenous Anti-Epstein-Barr Virus Antibodies Toward SARS-CoV-2 Spike.

  • Authors : Chêne A; INSERM, BIGR, Université Paris Cité, and Université des Antilles.; Desrames A

Subjects: Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/metabolism ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/immunology ; COVID-19*

  • Source: The Journal of infectious diseases [J Infect Dis] 2023 Dec 20; Vol. 228 (12), pp. 1675-1679.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Omicron BA.2.86 cross-neutralising activity in community sera from the UK.

  • Authors : Willett BJ; MRC University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.; Logan N

Subjects: Antibodies, Viral* ; Antibodies, Neutralizing*; Humans

  • Source: Lancet (London, England) [Lancet] 2023 Dec 02; Vol. 402 (10417), pp. 2075-2076. Date of Electronic Publication: 2023 Nov 09.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X

Record details

×
  • 10-20 of  115,848 results for ""Antibodies, Viral""